LobbyingThe Cure Coalition lobbying by quarter
The Cure Coalition's latest lobbying report covers Q2 2026, at $180K. The four quarters Q4 2025–Q3 2026 total $350K. Its first report covers Q4 2025; the issues it reports most are Health Issues and Budget/Appropriations.
The Cure Coalition
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $350K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $60K | 1 |
| Q1 2026 | $110K | 2 |
| Q2 2026 | $180K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$230K · 5 reports
- Budget and appropriations$120K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $240K | 3 quarters |
| The Bernhardt Group | $110K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| COLE ROJEWSKI | CoS, Rep. Kay Granger; Asst to Rep. Kay Granger, House Approp Cmte; Dir. of Congressional & Leg Affairs, DOI; Transition Advisor, Rep. Connie Conway; CoS, Deputy CoS, Office Manager, Transition Aide, Rep. David Valadao (CA); Field Rep,Rep.Devin Nunes | Q2 2026 |
| TAMZIN ASTANI | Professional Staff Member and Deputy Coalitions Director - House Budget Committee | Q2 2026 |
| KATE GONZALES | Policy Advisor, Sen. Sinema; Legislative Aide, Rep. Sinema; Legislative Correspondent, Rep. Sinema; Scheduler and Director of Operations, Rep. Sinema | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Forbes-Tate | $90K |
| 07/19for Q2 | The Bernhardt Group | $90K |
| 04/20for Q1 | The Bernhardt Group | $20K |
| 04/19for Q1 | Forbes-Tate | $90K |
| 04/07for Q1 | The Bernhardt Group | Under $5,000 |
| 01/18for Q4 2025 | Forbes-Tate | $60K |
| 01/13for Q4 2025 | Forbes-Tate | Under $5,000 |